Karnataka and Takeda Discuss Enhanced AI and Digital Health Collaborations in Bengaluru

The Karnataka government recently held significant discussions with leaders from Takeda Pharmaceutical, a global biopharmaceutical company, regarding the expansion of its Global Capability Centre (GCC) in Bengaluru. The high-level talks focused on leveraging Bengaluru's thriving technology ecosystem for advancements in digital transformation, cutting-edge research, and innovative product development. A key area of emphasis was Takeda's Bengaluru Innovation Capability Centre, which already plays a crucial role in supporting the company's global data, digital, and technology operations, particularly in AI-driven drug discovery, digital health solutions, and data science. The government highlighted Karnataka's strong biotechnology and medtech ecosystems, proposing collaborative opportunities with premier institutions like C-CAMP (Centre for Cellular and Molecular Platforms) and the Bangalore Bioinnovation Centre. This initiative underscores Karnataka's commitment to strengthening long-term partnerships with global innovation-led enterprises and cementing Bengaluru's reputation as a leading hub for life sciences, biotechnology, healthcare technology, and next-generation GCCs. Both parties expressed interest in further collaboration to accelerate innovation, foster talent development, and enhance translational research in the life sciences sector, reinforcing the state's position at the forefront of AI-driven biopharma innovation.